The Magazine for Sleep Professionals
Sunday, September 6, 2026
Chief polysomnographic technologist David Moore recently became the first sleep disorders tech in the world to be fully certified in the Inspire Care Pathway, which is a set of best practices that guide use of the Inspire upper airway stimulation device that is implanted to treat sleep apnea. The UAB […]
Two-incision approach reduces average procedure time by approximately 20 percent Inspire Medical Systems, Inc. has announced receipt of U.S. Food and Drug Administration (“FDA”) approval for an improved surgical implant procedure that eliminates one incision with a revised placement of the pressure sensing lead. This newly approved procedure will reduce […]
Inspire Medical Systems, Inc. (“Inspire”) announced today that Cigna, one of the leading health plans in the United States, will provide coverage for the Company’s Inspire therapy (hypoglossal nerve neurostimulation), effective June 15, 2020. Cigna Corporation is a global health service company that provides health insurance coverage for approximately 16 […]
Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (“FDA”) has approved an expanded age range for Inspire therapy to include 18-21-year-old patients, as compared to the previous minimum age requirement for patients to be 22 years old. Following a detailed review of the clinical evidence […]
Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), announced that three Medicare Administrative Contractors (“MACs”) have announced the effective release date of March 15, 2020, for their final Local Coverage Decision […]
Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced that two draft Local Coverage Determinations (LCDs) were published proposing coverage of Inspire therapy. The proposed draft LCDs are available on the Medicare […]
Inspire Medical Systems, Inc., developers of the Inspire hypoglossal nerve stimulator, a minimally invasive solution for patients with obstructive sleep apnea (“OSA”), recently revealed its new brand identity and launched a new website. “While our name and focus on patient outcomes remain the same, our brand identity and website, InspireSleep.com, have […]
Colin Huntley, MD will present a lecture entitled “The Use of Upper Airway Stimulation for the Management of Obstructive Sleep Apnea” at the 2018 Philadelphia Sleep Conference on March 23, 2018. This 60 minute lecture will include a review of the relevant tongue anatomy, discussion […]
